These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 20512539)

  • 1. How should we play our hand when holding an ACE?
    Beattie WS
    Can J Anaesth; 2010 Aug; 57(8):720-4. PubMed ID: 20512539
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antihypertensive drug therapy--combination of AT1-receptor blocker and betablocker].
    Schindler C; Kosa M; Schröder J; Kirch W
    Dtsch Med Wochenschr; 2010 May; 135(3):98. PubMed ID: 20077385
    [No Abstract]   [Full Text] [Related]  

  • 3. [Dual blockade of the renin-angiotensin system in hypertensive treatment: yes].
    Middeke M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2498. PubMed ID: 23168983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypertension 2007-2008].
    Chatzikyrkou C; Menne J; Haller H
    Med Klin (Munich); 2009 Aug; 104(8):614-21. PubMed ID: 19701732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative angioedema induced by angiotensin-converting enzyme inhibitors: overview and case report.
    O'Ryan F; Poor DB; Hattori M
    J Oral Maxillofac Surg; 2005 Apr; 63(4):551-6. PubMed ID: 15789330
    [No Abstract]   [Full Text] [Related]  

  • 6. ACE inhibitors and ARBs: antihypertensive medications in CKD.
    Szromba C
    Nephrol Nurs J; 2005; 32(3):332-3. PubMed ID: 16035474
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dual blockade of the renin-angiotensin system in hypertensive treatment: no].
    van der Giet M
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2499. PubMed ID: 23168984
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interview with Prof. Peter Dominiak, Lübeck. "Risk of diabetes with antihypertensive drugs is clinically relevant" (interview by Dr. Angelika Bischoff)].
    Dominiak P
    MMW Fortschr Med; 2004 Dec; 146(51-52):51. PubMed ID: 15675248
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
    Hanif K; Bid HK; Konwar R
    Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of the renin angiotensin system: proven benefits, unproven safety.
    Parfrey PS
    Ann Intern Med; 2008 Jan; 148(1):76-7. PubMed ID: 17984483
    [No Abstract]   [Full Text] [Related]  

  • 14. [Blocking the renin-angiotensin system in chronic kidney disease].
    Segura J
    Nefrologia; 2004; 24 Suppl(6):101-12, 187-235. PubMed ID: 15696901
    [No Abstract]   [Full Text] [Related]  

  • 15. [Inhibition of the renin angiotensin system in pregnancy and risk of fetal malformations].
    Lonati C; Morganti A
    Pediatr Med Chir; 2009; 31(3):137-9. PubMed ID: 19739495
    [No Abstract]   [Full Text] [Related]  

  • 16. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G
    Nephrol Ther; 2010 Jan; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract]   [Full Text] [Related]  

  • 17. Novel therapies blocking the renin-angiotensin-aldosterone system in the management of hypertension and related disorders.
    Krum H; Gilbert RE
    J Hypertens; 2007 Jan; 25(1):25-35. PubMed ID: 17143168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
    Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of angiotensin-converting enzyme inhibitors in vascular modulation: beyond the hypertensive effects.
    Katragadda S; Arora RR
    Am J Ther; 2010; 17(1):e11-23. PubMed ID: 20090429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure reduction is not the only determinant of outcome.
    Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR; Sever PS; Poulter NR; Elliott WJ; Jonsson MC; Black HR
    Circulation; 2006 Jun; 113(23):2754-72; discussion 2773-4. PubMed ID: 16769926
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.